Saturday, June 22, 2024 | Baltimore, MD

Emergent BioSolutions CEO Bob Kramer steps down, adviser named interim replacement

June 28, 2023

The chief executive of Emergent BioSolutions Inc. (NYSE: EBS) has stepped down. Bob Kramer, Emergent’s president and CEO since spring 2019 and a longtime executive with the Gaithersburg biotech, notified its board of directors Friday he would be retiring from his positions the next day, according to documents filed with the Securities and Exchange Commission. Kramer intends to stay on as an adviser to the company until Aug. 1.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.